Epidemiology and etiology of Parkinson’s disease: a review of the evidence

By K. Wirdefeldt, H. Adami, P. Cole, D. Trichopoulos, J. Mandel. European Journal of Epidemiology, 2011

1,232 citations recorded by the source corpus.

Subfields: Neurology

View Paper: https://www.semanticscholar.org/paper/8485cc12a65eca8e8c9a6d53db30d9a97dc884c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Chao Gao
2. Shengdi Chen
3. Yuyan Tan
4. Jingwen Jiang
5. B. Wieringa
6. G. Martens
7. Helena Xicoy

Citations in the corpus

• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023, methodology): “207 Two types of PD models are currently used in research: neurotoxin-induced and transgenic.”
• Neuroinflammation in Parkinson’s disease and its potential as therapeutic target (2015, background): “Introduction Parkinson’s disease (PD) is an age-related neurodegenerative disorder characterized clinically by resting tremor, slowness of movement, rigidity and postural instability and pathologically by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) ”
• Gut microbiota are related to Parkinson's disease and clinical phenotype (2015, background): “Which factors initiate the pathophysiological cascade in PD is unknown, but an environmental factor likely plays a key role, probably against a background of genetic vulnerability.(14,15) The early involvement of the gastrointestinal tract in PD lends support to the hypothesis that this environmenta”
• The SH-SY5Y cell line in Parkinson’s disease research: a systematic review (2017, background): “Parkinson’s disease (PD) is the second most common neurodegenerative disease with a predicted prevalence of 9 million people worldwide by 2030 [1, 2].”
• Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases (2015, background): “The motor symptoms appear when at least 60% of dopaminergic neurons are lost and 80–85% of dopamine content in the striatum is depleted (Jankovic, 2008; Wirdefeldt et al., 2011).”